Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up

Table 6

Drug dosing recommendations for telbivudine in CHB patients with CKD.

eGFR (mL/Min)	Dosage recommended
	Oral solution	Tablets
≥90	600 mg/day	600 mg/day
<90–60	600 mg/day	600 mg/day
<60–30	400 mg/day	600 mg every 48 hours
<30–15	200 mg/day	600 mg every 72 hours
<15	120 mg/day	600 mg every 96 hours
HD^*	120 mg/day	600 mg every 96 hours
CAPD	ND	ND

 ^*On hemodialysis days, telbivudine should be administered after the session.
eGFR: estimated glomerular filtration rate; ND: no data.
Source: http://www.sitegpr.com/.